Regulus has created leading strategic alliances with pharmaceutical partners that provide preclinical, clinical, and commercial expertise. In addition, Regulus has maintained active external collaborations with leading academic researchers since its inception. The extensive collaborative network with the world’s top laboratories positions Regulus at the leading edge of microRNA science, enabling Regulus to efficiently translate novel discoveries into therapeutic programs.
To pioneer a new paradigm
in treating serious diseases.
To create a high value company that produces a new class of high-impact medicines based on microRNA.
Questions or Inquiries: